jsctek_u4g7i52025-10-13T13:34:29+00:00SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketingjsctek_u4g7i52025-10-13T13:34:29+00:0024, Nov 2020|
jsctek_u4g7i52025-10-15T16:41:29+00:00SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™jsctek_u4g7i52025-10-15T16:41:29+00:0013, Nov 2020|
jsctek_u4g7i52025-10-13T13:44:37+00:00SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financingjsctek_u4g7i52025-10-13T13:44:37+00:004, Nov 2020|
jsctek_u4g7i52025-10-13T13:34:54+00:00FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Diseasejsctek_u4g7i52025-10-13T13:34:54+00:009, Jun 2020|
jsctek_u4g7i52025-10-13T13:35:01+00:00A Message from our CEO, Patrick Phelpsjsctek_u4g7i52025-10-13T13:35:01+00:0030, Apr 2020|
jsctek_u4g7i52025-10-15T16:39:34+00:00Sofie Biosciences Enters Strategic Collaboration For The Production And Distribution Of FAPI Precursorsjsctek_u4g7i52025-10-15T16:39:34+00:0010, Oct 2019|
